HomeCanon Medical Systems USACanon Medical Systems USA Reports Partnership With Zebra Medical Vision to Further Expand AI Offerings

Canon Medical Systems USA Reports Partnership With Zebra Medical Vision to Further Expand AI Offerings

Canon Medical Systems USA, Inc. has announced they are partnering with Zebra Medical Vision (Zebra-Med) to offer its AI1™ automated imaging analysis solutions to help clinicians in the U.S. provide faster, accurate diagnoses for optimized patient care.

Zebra Medical Vision technology provides cloud-based analysis of images through FDA-cleared AI solutions, trained on millions of patient scans to triage acute medical conditions, detect incidental findings, and stratify risk. This partnership with Canon Medical Systems USA, Inc. marks the introduction of Zebra-Med’s solution into the modality space, bringing AI analysis closer to the point of care.

“We are excited about the partnership with Canon Medical Systems USA, Inc., a company taking innovative and proactive steps to ensure AI adoption for better patient care. The integration of our solution into the modality space allows us to realize Zebra-Med’s vision of improving patient care at scale. Thanks to the strong product integration between the two companies, Canon Medical customers can save crucial time reaching acute cases faster, and enjoy AI insights directly in their workflow seamlessly,” said Ohad Arazi, CEO of Zebra Medical Vision.

“By partnering with Zebra-Med, Canon Medical Systems USA, Inc. is further proving our leadership and commitment to innovation in diagnostic imaging through accessible AI,” said Satrajit Misra, senior vice president, Marketing and Strategic Development, & acting vice president, Sales, Canon Medical Systems USA, Inc. “As we continue to expand our AI offerings across systems and modalities, we’re elevating the diagnostic imaging capabilities for our customers and providing more opportunities to improve patient care than ever before.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

Jonathan Chapman: New President/CEO of Trividia Health

Chapman said, “I’m honored to join the Trividia team as President and CEO. This organization has a long history of leadership within the healthcare industry as a provider of accurate, accessible, and affordable point-of-care solutions for the management of diabetes.”

SOLOPASS® System (Bedside Neuro-Navigation Device) Receives FDA 510(k) Clearance

inTRAvent’s SOLOPASS® system brings simple, portable, bedside neuro-navigation into the intensive care unit.

Skyhawk Therapeutics Completes New Investment Round

A $133 million round of investment will allow Skyhawk to accelerate development of its novel small molecule RNA-modifying drug candidates into the clinic.

By using this website you agree to accept Medical Device News Magazine Privacy Policy